Presentations.AI, a Beautiful.ai Alternative, Launches Unlimited-Seat Team Plan to Challenge Per-User Pricing, Adding Automatic Brand Sync and Document-to-Presentation Conversion Sorrento Therapeutics Mexico Executes Second Contract for Sale of 10 Million COVISTIX Tests for Mexico Market
SAN DIEGO and MEXICO CITY, Dec. 27, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq:…
Castellum Announces Signing of LOI to Acquire $4 Million Government Contractor
Castellum Announces Signing of LOI to Acquire $4 million government contractor Castellum, Inc. (OTC: ONOV)…
Faraday Pharmaceuticals Announces Publication of Results from its Phase 2 Study of FDY-5301 for the Treatment of Reperfusion Injury Following a STEMI Heart Attack
To be Published in the International Journal of Cardiology SEATTLE, Dec. 27, 2021 (GLOBE NEWSWIRE)…
Revolo Biotherapeutics Announces the Appointment of Tunde Otulana, M.D., to its Board of Directors
NEW ORLEANS and LONDON, Dec. 27, 2021 (GLOBE NEWSWIRE) — Revolo Biotherapeutics (“Revolo Bio” or…
TRACON Pharmaceuticals Announces Positive Results from the Independent Data Monitoring Committee Review of Interim Safety and Efficacy Data from the Ongoing ENVASARC Pivotal Trial
Pre-specified Interim Analysis Concluded with Recommendation to Continue the ENVASARC Trial Objective Response Rate (ORR)…
Celularity Receives Fast Track Designation from U.S. FDA for its NK Cell Therapy CYNK-001 in Development for the Treatment of AML
FLORHAM PARK, N.J., Dec. 27, 2021 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (“Celularity”), a…
Aclaris Therapeutics to Participate in the H.C. Wainwright BioConnect Virtual Conference
WAYNE, Pa., Dec. 27, 2021 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage…
Pluristem Reports Topline Results from its Phase II Studies of Acute Respiratory Distress Syndrome Associated with COVID-19
HAIFA, Israel, Dec. 27, 2021 (GLOBE NEWSWIRE) — Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI) (the “Company”),…
Pardes Biosciences Debuts as a Publicly Traded Company Focused on Oral Antiviral Therapies to Potentially Treat and Prevent COVID-19
Pardes Biosciences Main Protease Pardes Biosciences Main Protease PBI-0451 Pardes Biosciences PBI-0451 Oral Antiviral Pill…
BridgeBio Pharma Reports Month 12 Topline Results from Phase 3 ATTRibute-CM Study
– ATTRibute-CM did not meet its primary endpoint at Month 12. Mean observed six-minute walk…
BioNTech to Present at the 40th Annual J.P. Morgan Healthcare Conference
MAINZ, Germany, December 27, 2021 — BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced…
Moonstake to Support Staking of Everscale (EVER) in 2022
SINGAPORE, Dec 28, 2021 – (ACN Newswire) – Moonstake announced today it will implement staking…
ARRIVAL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Arrival SA and Encourages Investors to Contact the Firm
NEW YORK–(BUSINESS WIRE)–#ARVL–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces…
Ethos Asset Management Inc. USA Announces Deal in Gran Canaria, Spain with NEW ISLAND 2020 S.L., to Develop and Build a Leisure and Sports Destination called AIRE BEACH CLUB
Partnership Provides Long Term Financing to NEW ISLAND 2020 S.L., to build the most complete…
REPEAT/Athena Technology Acquisition Corp. Reminds Shareholders to Vote in Favor of Business Combination with Heliogen, Inc. at Next Week’s Extraordinary General Meeting of Shareholders
Information on how shareholders of record may vote their shares can be found at: https://www.athena1.com/athn-vote…
Fortive Announces Completion of Provation Acquisition From Clearlake Capital Group
EVERETT, Wash.–(BUSINESS WIRE)–Fortive Corporation (“Fortive”) (NYSE: FTV) announced today that it completed its previously announced…
Ingles Markets, Incorporated CFO Ron Freeman to Retire
ASHEVILLE, N.C.–(BUSINESS WIRE)–Ingles Markets, Incorporated (NASDAQ: IMKTA) announced today that its vice president-finance and chief…
CompoSecure and Roman DBDR Tech Acquisition Corp. Announce Closing of Business Combination
First Day of Trading on Nasdaq Global Market Under Ticker “CMPO” beginning December 28, 2021…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Arrival SA (ARVL) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Chegg, Inc. (CHGG) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…